CoChat
Sign Up
Cited by 64

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Codon optimization of the HPV-16 E5 gene enhances protein expression

Disbrow, Gary L, Sunitha, Iruvanti, Baker, Carl C, Hanover, John, Schlegel, Richard·2003·Virology
DOI 10.1016/s0042-6822(03)00129-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0042-6822(03)00129-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 54

  1. Adam, 2000, A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems, Virology, 272, 315, 10.1006/viro.2000.0376 · DOI
  2. Akerman, 2001, Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes, Cancer Res., 61, 3837
  3. Ashby, 2001, E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase, J. Gen. Virol., 82, 2353, 10.1099/0022-1317-82-10-2353 · DOI
  4. Bedell, 1989, Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells, J. Virol., 63, 1247, 10.1128/jvi.63.3.1247-1255.1989 · DOI · Paper page
  5. Berger, 2002, Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins, Am. J. Pathol., 161, 603, 10.1016/S0002-9440(10)64215-0 · DOI
  6. Bubb, 1988, DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein, Virology, 163, 243, 10.1016/0042-6822(88)90259-0 · DOI
  7. Burkhardt, 1987, Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein, EMBO J., 6, 2381, 10.1002/j.1460-2075.1987.tb02515.x · DOI
  8. Chang, 2001, The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix, J. Biomed. Sci., 8, 206, 10.1007/BF02256414 · DOI · Paper page
  9. Collier, 1998, Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2, J. Biol. Chem., 273, 22648, 10.1074/jbc.273.35.22648 · DOI
  10. Conrad, 1993, The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein, J. Virol., 67, 6170, 10.1128/jvi.67.10.6170-6178.1993 · DOI
  11. Conrad, 1994, The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors, Virology, 200, 796, 10.1006/viro.1994.1244 · DOI
  12. Crusius, 1997, Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein, Oncogene, 15, 1437, 10.1038/sj.onc.1201312 · DOI · Paper page
  13. Crusius, 1998, The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT, Exp. Cell Res., 241, 76, 10.1006/excr.1998.4024 · DOI · Paper page
  14. David, 1993, Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin), J. Biol. Chem., 268, 9585, 10.1016/S0021-9258(18)98391-2 · DOI
  15. Goldstein, 1991, Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases, Nature, 352, 347, 10.1038/352347a0 · DOI
  16. Goldstein, 1994, The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation, J. Virol., 68, 4432, 10.1128/jvi.68.7.4432-4441.1994 · DOI
  17. Goldstein, 1990, The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein, EMBO J., 9, 137, 10.1002/j.1460-2075.1990.tb08089.x · DOI
  18. Gu, 1995, Effect of human papillomavirus type 16 oncogenes on MAP kinase activity, J. Virol., 69, 8051, 10.1128/jvi.69.12.8051-8056.1995 · DOI · Paper page
  19. Haj, 2002, Imaging sites of receptor dephosphorylation by PTPIB on the surface of the endoplasmic reticulum, Science, 295, 1708, 10.1126/science.1067566 · DOI
  20. Halbert, 1988, Identification of the E5 open reading frame of human papillomavirus type 16, J. Virol., 62, 1071, 10.1128/jvi.62.3.1071-1075.1988 · DOI
  21. Hwang, 1995, The HPV16 E5 protein, Virology, 211, 227, 10.1006/viro.1995.1395 · DOI
  22. Kell, 1994, Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides, J. Gen. Virol., 75, 2451, 10.1099/0022-1317-75-9-2451 · DOI · Paper page
  23. Kozak, 1987, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucleic Acids Res., 15, 8125, 10.1093/nar/15.20.8125 · DOI
  24. Leder, 2001, Enhancement of capsid gene expression, J. Virol., 75, 9201, 10.1128/JVI.75.19.9201-9209.2001 · DOI
  25. Leechanachai, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus, Oncogene, 7, 19
  26. Lim, 1990, Specific interaction of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides, J. Infect. Dis., 162, 1263, 10.1093/infdis/162.6.1263 · DOI
  27. Luzio, 1990, Identification, sequencing and expression of an integral membrane protein of the trans-Golgi network (TGN38), Biochem. J., 270, 97, 10.1042/bj2700097 · DOI
  28. Mayer, 1998, Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b, Virology, 248, 208, 10.1006/viro.1998.9262 · DOI
  29. McMahon, 1993, Cellubrevin is a ubiquitous tetanus–toxin substrate homologous to a putative synaptic vesicle fusion protein, Nature, 364, 346, 10.1038/364346a0 · DOI
  30. Miesenbock, 1998, Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins, Nature, 394, 192, 10.1038/28190 · DOI
  31. Miller, 1989, Improved retroviral vectors for gene transfer and expression, Biotechniques, 7, 980
  32. Munger, 1989, The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes, J. Virol., 63, 4417, 10.1128/jvi.63.10.4417-4421.1989 · DOI · Paper page
  33. Pear, 1993, Production of high-titer helper-free retroviruses by transient transfection, Proc. Natl. Acad. Sci. USA, 90, 8392, 10.1073/pnas.90.18.8392 · DOI
  34. Petti, 1992, Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells, Proc. Natl. Acad. Sci. USA, 89, 6736, 10.1073/pnas.89.15.6736 · DOI
  35. Petti, 1991, Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein, EMBO J., 10, 845, 10.1002/j.1460-2075.1991.tb08017.x · DOI
  36. Pim, 1992, Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor, Oncogene, 7, 27
  37. Rodeck, 1997, EGF-R dependent regulation of keratinocyte survival, J. Cell Sci., 110, 113, 10.1242/jcs.110.2.113 · DOI
  38. Sankaranarayanan, 2000, The use of pHluorins for optical measurements of presynaptic activity, Biophys. J., 79, 2199, 10.1016/S0006-3495(00)76468-X · DOI
  39. Schapiro, 2000, Golgi alkalinization by the papillomavirus E5 oncoprotein, J. Cell Biol., 148, 305, 10.1083/jcb.148.2.305 · DOI
  40. Sparkowski, 1994, Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants, J. Virol., 68, 6120, 10.1128/jvi.68.9.6120-6123.1994 · DOI
  41. Stemmer, 1995, Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides, Gene, 164, 49, 10.1016/0378-1119(95)00511-4 · DOI
  42. Stoler, 1992, Human papillomavirus type 16 and 18 gene expression in cervical neoplasias, Hum. Pathol., 23, 117, 10.1016/0046-8177(92)90232-R · DOI
  43. Stoppler, 1996, The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA, Virology, 223, 251, 10.1006/viro.1996.0475 · DOI · Paper page
  44. Straight, 1995, The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes, J. Virol., 69, 3185, 10.1128/jvi.69.5.3185-3192.1995 · DOI
  45. Straight, 1993, The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes, J. Virol., 67, 4521, 10.1128/jvi.67.8.4521-4532.1993 · DOI · Paper page
  46. Suprynowicz, 2000, E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation, J. Biol. Chem., 275, 5111, 10.1074/jbc.275.7.5111 · DOI
  47. Tanimoto, 1991, [Detection of HPV type 16 early genes E7 and E5 messenger RNA in uterine cervical neoplasia by reverse transcriptase polymerase chain reaction], Nippon Sanka Fujinka Gakkai Zasshi, 43, 1255
  48. Thomsen, 2000, The HPV16 E5 oncogene inhibits endocytic trafficking, Oncogene, 19, 6023, 10.1038/sj.onc.1204010 · DOI
  49. Valle, 1995, The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells, J. Gen. Virol., 76, 1239, 10.1099/0022-1317-76-5-1239 · DOI · Paper page
  50. Vousden, 1988, The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene, Oncogene Res., 3, 167
  51. Yarden, 1988, Growth factor receptor tyrosine kinases, Annu. Rev. Biochem., 57, 443, 10.1146/annurev.bi.57.070188.002303 · DOI
  52. Zhang, 2002, E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis, J. Virol., 76, 220, 10.1128/JVI.76.1.220-231.2002 · DOI · Paper page
  53. Zhou, 1999, Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability, J. Virol., 73, 4972, 10.1128/JVI.73.6.4972-4982.1999 · DOI
  54. zur Hausen, 2001, Oncogenic DNA viruses, Oncogene, 20, 7820, 10.1038/sj.onc.1204958 · DOI

Cited by

Metadata

Authors
Disbrow, G. L., Sunitha, I., Baker, C. C., Hanover, J., & Schlegel, R.
Venue
Virology
Publisher
Elsevier BV
Published
2003-06
Volume
311
Issue
1
Pages
105-114
ISSN
0042-6822
DOI
10.1016/s0042-6822(03)00129-6
Cited by
64
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review